OECD Home › Competition › By Date
This report compares the performance of the French innnovation systems with that of other countries and presents the conclusions of interviews with 30 key actors in the French research and innovation system. During the past ten years, this system has undergone profound changes, and the report highlights the governments plan to dynamise and reform the system.
Costa Rica's competition system underwent a peer review of its laws and regulations at the 2014 Latin American Competition Forum on 16-17 September 2014. The report was launched in San José on 4 December 2014 and provides a through insight into the current strengths and weakness of the Costa Rican competition regime.
Good competition laws require well-designed institutions to apply them. Given recent trends in changes in institutional design of competition authorities, the Competition Committee will be holding a roundtable in December 2014 to learn more from countries experiences.
Competition delegates discussed in June 2014 the financing of roll-out of broadband networks and examined alternative ways in which governments are ensuring the deployment of the infrastructure necessary to ensure high speed broadband access across their territory. Read more about the discussion.
Entry by generic pharmaceuticals can enhance competition, but innovation should be, at the same time, enhanced by allowing innovators to obtain intellectual property rights on their originator drug. The Competition Committee discussed these issues in June 2014.
Air transport has radically evolved over the last two decades. Liberalisation and deregulation of the sector have facilitated the entry of new firms, which has had a positive impact on competition. The OECD Competition Committee discussed Airline Competition in June 2014.
Each year, the Competition Committee holds several Best Practice Roundtables. This list contains links to the proceedings from these roundtables from 1995 to the present date.
Pharmaceuticals are special products due to special characteristics in supply and demand. Their distribution is heavily regulated to ensure that drugs are accessible, affordable, and safely consumed. Competition can and should play a role in ensuring that the pharmaceuticals distribution market works well for consumers. The 2014 Global Forum on Competition addressed competition issues in the distribution of pharmaceuticals.
OECD-GVH Regional Centre for Competition in Budapest website
Governments are increasingly assessing the effects of their policies and effectiveness of public institutions, and competition agencies are no exception. This factsheet was elaborated to help competition agencies advocate their work. It contains evidence on the links between competition and macro-economic outcomes.